2010
DOI: 10.1902/jop.2010.100031
|View full text |Cite
|
Sign up to set email alerts
|

The Combined Use of Nd:YAG Laser and Enamel Matrix Proteins in the Treatment of Periodontal Infrabony Defects

Abstract: Within the limits of the present study, it may be concluded that both therapies led to improvements of the clinical parameters, and Nd:YAG laser root conditioning as used in this study compared to EDTA root conditioning did not improve the outcome of EMP use.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

4
29
0
1

Year Published

2013
2013
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 20 publications
(34 citation statements)
references
References 62 publications
4
29
0
1
Order By: Relevance
“…Other studies 26 , 37 , 39 are in agreement with the present findings. In a comparative evaluation 37 of the efficiency of the diode laser as an adjunct to mechanical debridement versus conventional mechanical debridement in periodontal open flap surgery, no difference was found between laser‐treated and non–laser‐treated groups with regard to clinical parameters.…”
Section: Discussionsupporting
confidence: 94%
See 2 more Smart Citations
“…Other studies 26 , 37 , 39 are in agreement with the present findings. In a comparative evaluation 37 of the efficiency of the diode laser as an adjunct to mechanical debridement versus conventional mechanical debridement in periodontal open flap surgery, no difference was found between laser‐treated and non–laser‐treated groups with regard to clinical parameters.…”
Section: Discussionsupporting
confidence: 94%
“…Contrary to previous findings 38 , 40 , 42 and in agreement with ours, Dilsiz et al 39 compared the clinical outcomes of enamel matrix proteins (EMP) alone and combined with Nd:YAG laser in the treatment of infrabony defects. They reported that the use of Nd:YAG laser did not have superiority over EDTA as a root conditioning agent 39 .…”
Section: Discussionsupporting
confidence: 70%
See 1 more Smart Citation
“…This clinical trial revealed similar CAL‐V gain in infrabony defects with an INFRA of 4.8 mm (DOXY) and 5.2 mm (PLAC) 12 months after therapy using EMD compared with results reported by others 12 months after EMD in similar or more favorable defects: In moderately deep (5.6 mm) 1‐ and 2‐wall defects, CAL‐V gains of 1.9 mm were reported 27 and in deep (8.5 mm) non‐contained infrabony defects, CAL‐V gains of 2.4 mm were reported 32 . In deep (6.8 mm) 2‐ and 3‐wall defects, CAL‐V gains of 3 mm was observed 33 . Furthermore, 12 months after treatment, mean CAL‐V gain of 3.4 mm 34 and 4.7 mm was achieved in defects with 6.1 mm INFRA 35 .…”
Section: Discussionmentioning
confidence: 99%
“…Here again, none of the average differences, regardless of clinical parameter, can be considered clinically significant. The reductions in subgingival microbial loads are not significant primarily because six 37,38,42‐44,46 of the eight studies did not measure this parameter, and the remaining two studies found no significant difference between treatment groups.…”
Section: The Datamentioning
confidence: 92%